Literature DB >> 10408260

Autism: not an extremely rare disorder.

C Gillberg1, L Wing.   

Abstract

OBJECTIVE: To study autism over time in order to ascertain whether there has been an increase in its prevalence in recent years.
METHOD: All English language papers on the prevalence of autism were reviewed. Ten of the studies retrieved were not used in the final analysis because they did not meet full criteria for inclusion in the review. The remaining 20 studies, published between 1966 and 1997, were subdivided into US studies (n=2) and non-US studies (n=18), and the latter group was subdivided into four 8-year periods.
RESULTS: The early studies yielded prevalence rates of under 0.5 in 1000 children, whereas the later ones showed a mean rate of about 1 in 1000. There was a marked difference in prevalence rates between those studies that included some children born before 1970 (low rates) and those that included only children born in 1970 and after (high rates). This is probably due to the lower rates obtained by use of criteria strictly based on Kanner's description of his syndrome. The US studies reported atypically low rates. There was a highly significant estimated increase with calendar year in the non-US studies (3.8% per year).
CONCLUSION: It is concluded that autism is considerably more common than was previously believed. The possible reasons for the higher reported rates are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10408260     DOI: 10.1111/j.1600-0447.1999.tb00984.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  61 in total

1.  Prevalence of autism in early 1970s may have been underestimated.

Authors:  H Heussler; L Polnay; E Marder; P Standen; L U Chin; N Butler
Journal:  BMJ       Date:  2001-09-15

2.  The rising prevalence of autism: a prospective longitudinal study in the Faroe Islands.

Authors:  Eva Kočovská; Rannvá Biskupstø; I Carina Gillberg; Asa Ellefsen; Hanna Kampmann; Tormóður Stórá; Eva Billstedt; Christopher Gillberg
Journal:  J Autism Dev Disord       Date:  2012-09

3.  Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood.

Authors:  Eva Billstedt; I Carina Gillberg; Carina Gillberg; Christopher Gillberg
Journal:  J Autism Dev Disord       Date:  2005-06

Review 4.  Oxytocin, vasopressin and pair bonding: implications for autism.

Authors:  Elizabeth A D Hammock; Larry J Young
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

5.  Prevalence of autistic spectrum disorders in Lothian, Scotland: an estimate using the "capture-recapture" technique.

Authors:  M J Harrison; A E O'Hare; H Campbell; A Adamson; J McNeillage
Journal:  Arch Dis Child       Date:  2006-01       Impact factor: 3.791

Review 6.  Autism: an emerging public health problem.

Authors:  Craig J Newschaffer; Laura Kresch Curran
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

7.  Mathematical modeling of the methionine cycle and transsulfuration pathway in individuals with autism spectrum disorder.

Authors:  Troy Vargason; Daniel P Howsmon; Stepan Melnyk; S Jill James; Juergen Hahn
Journal:  J Theor Biol       Date:  2016-12-29       Impact factor: 2.691

8.  Autism with ophthalmologic malformations: the plot thickens.

Authors:  Marilyn T Miller; Kerstin Strömland; Liana Ventura; Maria Johansson; Jose M Bandim; Christopher Gillberg
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  How relevant are GFAP autoantibodies in autism and Tourette Syndrome?

Authors:  Nikki J Kirkman; Jane E Libbey; Thayne L Sweeten; Hilary H Coon; Judith N Miller; Edward K Stevenson; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Autism Dev Disord       Date:  2007-06-20

10.  The Autism Observation Scale for Infants: scale development and reliability data.

Authors:  Susan E Bryson; Lonnie Zwaigenbaum; Catherine McDermott; Vicki Rombough; Jessica Brian
Journal:  J Autism Dev Disord       Date:  2007-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.